FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize

Mark Ziats
Mar 16
1 min read

Compounded versions of Semaglutide (Ozempic / Wegovy) and Tirzepitide (Monjuro and Zepbound) are no longer legal, with further FDA clarity on the topic published this week, see below:

Source: U.S. Food and Drug Administration

https://search.app/B4vGMyqR4U2utjAv8

See my recent summary of this topic here:

https://www.ziatsmedical.com/post/compounded-glp-1-semaglutide-tirzaperatide-drugs-in-2025

Recent Posts

See All

Early TAVR for asymptomatic aortic stenosis

There have been many ongoing trials on this topic and they are finally starting to conclude that intervening early, even when the patient is asymptomatic, is beneficial once echocardiogram shows the p

Vaginal Estrogen and Stroke Risk

We get a lot of questions from women who would benefit from vaginal/topical estrogen but are appropriately concerned about increased risk for heart attack and stroke with estrogen supplementation. A n

Insomnia in Primary Care

Comments